Eleven small and medium enterprises will benefit from a total of £2.2 million of funding from the Biotechnology and Biological Sciences Research Council under its Small Business Research Initiative. The firms are Critical Pharmaceuticals Ltd, Nottingham; Daniolabs, Cambridge; deltaDOT Ltd, London; Celltran Ltd, Sheffield; Farfield Sensors Ltd, Salford; Oxitec Ltd, Oxford; MedPharm Ltd, Charlbury, Oxfordshire; Lumora Ltd, Cambridge; Plasso Technology Ltd, Sheffield; Southampton PolyPeptides Ltd, Southampton; Zyentia Ltd, Cambridge.